Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia

Starting soon · Not applicable · Has a placebo group

Conditions studied: Insomnia, Primary

In brief

The purpose of this study was to understand the effectiveness of intermittent hypoxia in the treatment of primary insomnia.

Key facts

Study ID

NCT07394699

Run by

Capital Medical University

People needed

30

Starts

2026-04-01

Expected to finish

2028-12-31

Last updated by the study team

2026-02-06

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects are diagnosed with primary insomnia between 18 and 60 years old，gender is not limited.
• Patients who are not taking sedative-hypnotic drugs or have stopped taking drugs for more than 2 weeks.
• Residing in the plains all year round and not having been above 1500 meters above sea level in the past 30 days.
• Quiet state SaO2 ≥ 90%, cerebral oxygen saturation 58-82%, heart rate 60-100 beats/min, blood pressure 90-140/60-90 mmHg, respiratory rate 16-20 times/min.
• No functional drinks, caffeine-containing beverages, or sleep-disturbing medications during the study period.

You may not qualify if…

• Stroke onset in the past 3 months, other severe neurological diseases, such as epilepsy, intracranial infectious diseases or demyelination.
• Uncontrolled hypertension (systolic blood pressure ≥200mmHg) with antihypertensive drugs before enrollment, other cardiovascular diseases.
• History of pulmonary, hepatic, dermatologic, or hematologic diseases.
• History of substance abuse.
• Pregnancy, Severe sleep apnea and neurological disorders.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.